Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
33
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dillione Janet | Director | 79 | $26.32M | $1.55M | 2026-09-18 |
| Zelnick Kaufman Beth | Chief Legal Officer | 20 | $0 | $670.3K | 2026-08-29 |
| Blum Susan | Chief Financial Officer | 5 | $0 | $0 | 2026-08-29 |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | 45 | $0 | $2.33M | 2026-08-29 |
| Todisco Joseph | Chief Executive Officer | 34 | $239.3K | $1.01M | 2026-02-04 |
| Duncan Gregory Scott | Director | 10 | $0 | $0 | 2026-01-26 |
| Kaplan Myron | Director | 49 | $1.03M | $0 | 2026-01-26 |
| Stewart Robert A | Director | 7 | $43.7K | $0 | 2026-01-26 |
| Lefkowitz Steven W | Interim Chief Financial Office | 91 | $160.7K | $962.3K | 2026-01-26 |
| DUNTON ALAN W | Director | 22 | $53.0K | $391.3K | 2026-01-26 |
| Seckler Michael David | Chief Commercial Officer | 1 | $0 | $0 | 2026-01-08 |
| Mistry Erin | EVP, Chief Commercial Officer | 9 | $19.0K | $0 | 2025-01-10 |
| David Matthew T | Interim CEO and CFO | 16 | $18.8K | $0 | 2025-01-10 |
| Costa Paulo F | Director | 7 | $46.5K | $0 | 2023-05-17 |
| Mounts Phoebe | General Counsel | 11 | $30.1K | $0 | 2023-01-14 |
| Nusbickel Thomas | EVP, Chief Commercial Officer | 3 | $0 | $0 | 2022-02-18 |
| Baluch Khoso | Chief Executive Officer | 20 | $197.4K | $0 | 2021-01-11 |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | 18 | $552.6K | $0 | 2021-01-11 |
| Khan Mehmood | Director | 22 | $639.8K | $0 | 2020-08-19 |
| Cook Robert W. | Chief Financial Officer | 11 | $103.4K | $0 | 2019-09-30 |
| Gelbfish Gary A. | Director | 32 | $25.0K | $0 | 2019-01-10 |
| TELLEZ CORA M | Director | 33 | $26.16M | $0 | 2017-05-30 |
| Markvicka Taunia | Director | 8 | $57.3K | $0 | 2017-05-15 |
| GEORGE MICHAEL W | Director | 17 | $26.05M | $0 | 2017-05-15 |
| Pfaffle Antony | Interim Chief Medical Officer | 67 | $0 | $748.3K | 2017-02-07 |
| Abrams Judith R | Chief Medical Officer | 2 | $0 | $0 | 2017-01-30 |
| MILBY RANDY | Chief Operating Officer | 40 | $130.0K | $0 | 2016-08-09 |
| Duffy Matthew | Director | 32 | $0 | $514.7K | 2016-06-03 |
| O'Grady Harry | Chief Financial Officer | 1 | $0 | $0 | 2014-07-21 |
| Cohen Richard | SEE REMARKS | 2 | $0 | $0 | 2013-03-20 |
| PHARMABIO DEVELOPMENT INC | 10% Owner | 1 | $0 | $5.0K | 2012-04-12 |
| LENZ BRIAN | SEE REMARKS | 1 | $0 | $0 | 2012-03-20 |
| HOFER TIMOTHY M | Director | 1 | $0 | $0 | 2012-01-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Dillione Janet | Director | M Exercise deriv | 2026-09-18 | 2026-09-18 | 48,909 | — | $0 | 0 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2026-09-18 | 2026-09-18 | 48,909 | — | $0 | 117,835 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2026-09-18 | 2026-09-18 | 48,909 | — | — | 0 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2026-09-18 | 2026-09-18 | 48,909 | — | — | 117,835 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2026-08-29 | 2026-09-01 | 8,424 | $8.30 | $69.9K | 260,684 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | F Tax w/h | 2026-08-29 | 2026-09-01 | 8,076 | $8.30 | $67.0K | 270,463 | SEC↗ |
| Blum Susan | Chief Financial Officer | F Tax w/h | 2026-08-29 | 2026-09-01 | 8,424 | $8.30 | $69.9K | 124,315 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | F Tax w/h | 2026-08-29 | 2026-09-01 | 8,076 | $8.30 | $67.0K | 270,463 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2026-08-29 | 2026-09-01 | 8,424 | $8.30 | $69.9K | 260,684 | SEC↗ |
| Blum Susan | Chief Financial Officer | F Tax w/h | 2026-08-29 | 2026-09-01 | 8,424 | $8.30 | $69.9K | 124,315 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award | 2026-02-04 | 2026-02-06 | 77,156 | — | $0 | 774,749 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | A Award | 2026-02-04 | 2026-02-06 | 36,006 | — | $0 | 278,539 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | A Award | 2026-02-04 | 2026-02-06 | 36,006 | — | $0 | 269,108 | SEC↗ |
| Duncan Gregory Scott | Director | A Award | 2026-01-26 | 2026-01-27 | 30,453 | — | $0 | 68,786 | SEC↗ |
| Kaplan Myron | Director | A Award | 2026-01-26 | 2026-01-27 | 30,453 | — | $0 | 231,487 | SEC↗ |
| Lefkowitz Steven W | Director | A Award | 2026-01-26 | 2026-01-27 | 30,453 | — | $0 | 125,951 | SEC↗ |
| DUNTON ALAN W | Director | A Award | 2026-01-26 | 2026-01-27 | 30,453 | — | $0 | 70,703 | SEC↗ |
| Stewart Robert A | Director | A Award | 2026-01-26 | 2026-01-27 | 30,453 | — | $0 | 66,453 | SEC↗ |
| Dillione Janet | Director | A Award | 2026-01-26 | 2026-01-27 | 30,453 | — | $0 | 68,926 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2026-01-23 | 2026-01-27 | 27,306 | $7.27 | $198.5K | 697,593 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award | 2026-01-23 | 2026-01-27 | 225,900 | — | $0 | 724,899 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | A Award | 2026-01-23 | 2026-01-27 | 93,010 | — | $0 | 253,311 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | F Tax w/h | 2026-01-23 | 2026-01-27 | 10,778 | $7.27 | $78.4K | 242,533 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | A Award | 2026-01-23 | 2026-01-27 | 72,820 | — | $0 | 241,905 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2026-01-23 | 2026-01-27 | 8,803 | $7.27 | $64.0K | 233,102 | SEC↗ |
| Blum Susan | Chief Financial Officer | A Award | 2026-01-23 | 2026-01-27 | 72,820 | — | $0 | 142,506 | SEC↗ |
| Blum Susan | Chief Financial Officer | F Tax w/h | 2026-01-23 | 2026-01-27 | 9,767 | $7.27 | $71.0K | 132,739 | SEC↗ |
| Dillione Janet | Director | S Sale | 2026-01-21 | 2026-01-22 | 10,000 | $6.88 | $68.8K | 38,473 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2026-01-17 | 2026-01-20 | 22,665 | $6.78 | $153.7K | 498,999 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise deriv | 2026-01-16 | 2026-01-20 | 29,585 | — | $0 | 411,245 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise | 2026-01-16 | 2026-01-20 | 29,585 | $3.38 | $100.0K | 521,664 | SEC↗ |
| Lefkowitz Steven W | Director | M Exercise deriv | 2026-01-12 | 2026-01-14 | 15,000 | — | $0 | 0 | SEC↗ |
| Lefkowitz Steven W | Director | M Exercise | 2026-01-12 | 2026-01-14 | 15,000 | $5.63 | $84.5K | 95,498 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2026-01-12 | 2026-01-20 | 17,417 | $7.15 | $124.5K | 492,079 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | F Tax w/h | 2026-01-12 | 2026-01-20 | 5,794 | $7.15 | $41.4K | 160,301 | SEC↗ |
| Seckler Michael David | Chief Commercial Officer | A Award | 2026-01-08 | 2026-01-15 | 133,156 | — | $0 | 133,156 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2026-01-02 | 2026-01-06 | 11,333 | $12.16 | $137.8K | 169,085 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | F Tax w/h | 2026-01-02 | 2026-01-06 | 10,895 | $12.16 | $132.5K | 166,095 | SEC↗ |
| DUNTON ALAN W | Director | M Exercise deriv | 2025-12-30 | 2026-01-02 | 20,000 | — | $0 | 0 | SEC↗ |
| DUNTON ALAN W | Director | S Sale | 2025-12-30 | 2026-01-02 | 20,000 | $13.00 | $260.0K | 40,250 | SEC↗ |
| DUNTON ALAN W | Director | M Exercise | 2025-12-30 | 2026-01-02 | 20,000 | $4.03 | $80.6K | 60,250 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise deriv | 2025-12-18 | 2025-12-19 | 30,000 | — | $0 | 370,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | S Sale | 2025-12-18 | 2025-12-19 | 30,000 | $12.00 | $360.0K | 509,496 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise | 2025-12-18 | 2025-12-19 | 30,000 | $4.43 | $132.9K | 539,496 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-12-09 | 2025-12-11 | 15,000 | — | $0 | 0 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-12-09 | 2025-12-11 | 19,000 | — | $0 | 0 | SEC↗ |
| Lefkowitz Steven W | Director | S Sale | 2025-12-09 | 2025-12-10 | 40,000 | $11.88 | $475.2K | 80,498 | SEC↗ |
| Dillione Janet | Director | S Sale | 2025-12-09 | 2025-12-11 | 34,000 | $12.00 | $408.0K | 48,473 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-12-09 | 2025-12-11 | 19,000 | $9.55 | $181.4K | 67,473 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-12-09 | 2025-12-11 | 15,000 | $5.63 | $84.5K | 82,473 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-12-02 | 2025-12-04 | 19,323 | — | $0 | 5,000 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-12-02 | 2025-12-04 | 12,210 | — | $0 | 0 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-12-02 | 2025-12-04 | 15,124 | — | $0 | 0 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-12-02 | 2025-12-04 | 19,323 | $3.55 | $68.6K | 95,130 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-12-02 | 2025-12-04 | 15,124 | $4.43 | $67.0K | 75,807 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-12-02 | 2025-12-04 | 12,210 | $4.03 | $49.2K | 60,683 | SEC↗ |
| Dillione Janet | Director | S Sale | 2025-12-02 | 2025-12-04 | 46,657 | $10.00 | $466.6K | 48,473 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-11-24 | 2025-11-26 | 5,677 | — | $0 | 24,323 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-11-24 | 2025-11-26 | 4,876 | — | $0 | 15,124 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-11-24 | 2025-11-26 | 8,000 | — | $0 | 0 | SEC↗ |
| Dillione Janet | Director | M Exercise deriv | 2025-11-24 | 2025-11-26 | 7,790 | — | $0 | 12,210 | SEC↗ |
| Dillione Janet | Director | S Sale | 2025-11-24 | 2025-11-26 | 26,343 | $9.93 | $261.6K | 48,473 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-11-24 | 2025-11-26 | 8,000 | $2.85 | $22.8K | 56,473 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-11-24 | 2025-11-26 | 4,876 | $4.43 | $21.6K | 69,139 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-11-24 | 2025-11-26 | 5,677 | $3.55 | $20.2K | 74,816 | SEC↗ |
| Dillione Janet | Director | M Exercise | 2025-11-24 | 2025-11-26 | 7,790 | $4.03 | $31.4K | 64,263 | SEC↗ |
| Dillione Janet | Director | S Sale | 2025-11-14 | 2025-11-18 | 30,000 | $11.42 | $342.6K | 48,473 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2025-10-23 | 2025-10-27 | 25,000 | $11.02 | $275.5K | 201,034 | SEC↗ |
| Duncan Gregory Scott | Director | M Exercise deriv | 2025-09-16 | 2025-09-18 | 13,333 | — | $0 | 6,667 | SEC↗ |
| Duncan Gregory Scott | Director | M Exercise | 2025-09-16 | 2025-09-18 | 13,333 | $8.32 | $110.9K | 38,333 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise deriv | 2025-09-12 | 2025-09-12 | 50,000 | — | $0 | 216,667 | SEC↗ |
| DUNTON ALAN W | Director | M Exercise deriv | 2025-09-12 | 2025-09-16 | 10,000 | — | $0 | 20,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise | 2025-09-12 | 2025-09-12 | 50,000 | $3.47 | $173.5K | 559,496 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | S Sale | 2025-09-12 | 2025-09-12 | 50,000 | $13.00 | $650.0K | 509,496 | SEC↗ |
| DUNTON ALAN W | Director | S Sale | 2025-09-12 | 2025-09-16 | 10,000 | $13.13 | $131.3K | 40,250 | SEC↗ |
| DUNTON ALAN W | Director | M Exercise | 2025-09-12 | 2025-09-16 | 10,000 | $3.55 | $35.5K | 50,250 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | M Exercise deriv | 2025-09-11 | 2025-09-11 | 41,121 | — | $0 | 0 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | S Sale | 2025-09-11 | 2025-09-11 | 41,121 | $13.08 | $537.9K | 176,990 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | M Exercise | 2025-09-11 | 2025-09-11 | 41,121 | $1.45 | $59.6K | 218,111 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | M Exercise deriv | 2025-09-09 | 2025-09-11 | 12,876 | — | $0 | 41,121 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | M Exercise deriv | 2025-09-09 | 2025-09-11 | 50,000 | — | $0 | 150,000 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | M Exercise | 2025-09-09 | 2025-09-11 | 12,876 | $1.45 | $18.7K | 189,866 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | S Sale | 2025-09-09 | 2025-09-11 | 12,876 | $13.51 | $174.0K | 176,990 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | S Sale | 2025-09-09 | 2025-09-11 | 400 | $12.82 | $5.1K | 180,418 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | M Exercise | 2025-09-09 | 2025-09-11 | 50,000 | $3.30 | $165.0K | 230,418 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | S Sale | 2025-09-09 | 2025-09-11 | 49,600 | $13.41 | $665.1K | 180,818 | SEC↗ |
| Blum Susan | Chief Financial Officer | A Award | 2025-08-29 | 2025-09-03 | 69,686 | — | $0 | 69,686 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | A Award | 2025-08-29 | 2025-09-03 | 69,686 | — | $0 | 189,298 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | A Award | 2025-08-29 | 2025-09-03 | 69,686 | — | $0 | 185,414 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2025-08-29 | 2025-09-08 | 8,880 | $14.83 | $131.7K | 180,418 | SEC↗ |
| Hurlburt Elizabeth | Chief Operating Officer | F Tax w/h | 2025-08-29 | 2025-09-08 | 8,424 | $14.83 | $124.9K | 176,990 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2025-05-10 | 2025-09-12 | 21,225 | $11.66 | $247.5K | 509,496 | SEC↗ |
| Lefkowitz Steven W | Director | M Exercise deriv | 2025-04-02 | 2025-04-03 | 20,000 | — | $0 | 0 | SEC↗ |
| Lefkowitz Steven W | Director | M Exercise | 2025-04-02 | 2025-04-03 | 20,000 | $4.03 | $80.6K | 120,498 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise deriv | 2025-04-01 | 2025-04-02 | 59,170 | — | $0 | 440,830 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | M Exercise | 2025-04-01 | 2025-04-02 | 59,170 | $3.38 | $200.0K | 530,721 | SEC↗ |
| Duncan Gregory Scott | Director | A Award | 2025-01-17 | 2025-01-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lefkowitz Steven W | Director | A Award | 2025-01-17 | 2025-01-22 | 25,000 | — | $0 | 100,498 | SEC↗ |
| Kaplan Myron | Director | A Award | 2025-01-17 | 2025-01-22 | 25,000 | — | $0 | 176,034 | SEC↗ |
| Dillione Janet | Director | A Award | 2025-01-17 | 2025-01-22 | 25,000 | — | $0 | 78,473 | SEC↗ |
| Stewart Robert A | Director | A Award | 2025-01-17 | 2025-01-22 | 25,000 | — | $0 | 36,000 | SEC↗ |
| DUNTON ALAN W | Director | A Award | 2025-01-17 | 2025-01-22 | 25,000 | — | $0 | 40,250 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2025-01-17 | 2025-01-22 | 23,977 | $12.17 | $291.8K | 471,551 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award | 2025-01-17 | 2025-01-22 | 187,500 | — | $0 | 495,528 | SEC↗ |
| Hurlburt Elizabeth | EVP | F Tax w/h | 2025-01-10 | 2025-01-14 | 5,790 | $11.19 | $64.8K | 115,728 | SEC↗ |
| Mistry Erin | EVP, Chief Commercial Office | F Tax w/h | 2025-01-10 | 2025-01-14 | 5,689 | $11.19 | $63.7K | 100,992 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2025-01-10 | 2025-01-14 | 17,829 | $11.19 | $199.5K | 308,028 | SEC↗ |
| David Matthew T | Chief Financial Officer | F Tax w/h | 2025-01-10 | 2025-01-14 | 6,515 | $11.19 | $72.9K | 95,270 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | A Award | 2025-01-02 | 2025-01-06 | 87,500 | — | $0 | 131,456 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2025-01-02 | 2025-01-06 | 11,844 | $8.22 | $97.4K | 119,612 | SEC↗ |
| David Matthew T | Chief Financial Officer | F Tax w/h | 2025-01-02 | 2025-01-06 | 8,648 | $8.22 | $71.1K | 101,786 | SEC↗ |
| David Matthew T | Chief Financial Officer | A Award | 2025-01-02 | 2025-01-06 | 62,500 | — | $0 | 110,434 | SEC↗ |
| Hurlburt Elizabeth | EVP | A Award | 2025-01-02 | 2025-01-06 | 87,500 | — | $0 | 132,897 | SEC↗ |
| Hurlburt Elizabeth | EVP | F Tax w/h | 2025-01-02 | 2025-01-06 | 11,378 | $8.22 | $93.5K | 121,519 | SEC↗ |
| Mistry Erin | EVP, Chief Commercial Office | F Tax w/h | 2025-01-02 | 2025-01-06 | 7,830 | $8.22 | $64.4K | 106,681 | SEC↗ |
| Mistry Erin | EVP, Chief Commercial Office | A Award | 2025-01-02 | 2025-01-06 | 62,500 | — | $0 | 114,511 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | M Exercise deriv | 2024-12-12 | 2024-12-16 | 12,500 | — | $0 | 37,500 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2024-12-12 | 2024-12-16 | 6,044 | $8.77 | $53.0K | 56,456 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | M Exercise | 2024-12-12 | 2024-12-16 | 12,500 | — | $0 | 62,500 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | F Tax w/h | 2024-12-12 | 2024-12-18 | 6,044 | $8.77 | $53.0K | 43,956 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise deriv | 2024-11-14 | 2024-11-18 | 34,467 | — | $0 | 3,033 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise deriv | 2024-11-14 | 2024-11-18 | 9,888 | — | $0 | 27,612 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise deriv | 2024-11-14 | 2024-11-18 | 8,169 | — | $0 | 12,711 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise deriv | 2024-11-14 | 2024-11-18 | 3 | — | $0 | 53,997 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise deriv | 2024-11-14 | 2024-11-18 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise deriv | 2024-11-14 | 2024-11-18 | 25,000 | — | $0 | 75,000 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise | 2024-11-14 | 2024-11-18 | 3 | $1.45 | $4 | 45,400 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise | 2024-11-14 | 2024-11-18 | 8,169 | $8.30 | $67.8K | 53,569 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise | 2024-11-14 | 2024-11-18 | 9,888 | $5.63 | $55.7K | 63,457 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise | 2024-11-14 | 2024-11-18 | 34,467 | $4.08 | $140.6K | 97,924 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise | 2024-11-14 | 2024-11-18 | 62,500 | $4.43 | $276.9K | 160,424 | SEC↗ |
| Hurlburt Elizabeth | EVP | M Exercise | 2024-11-14 | 2024-11-18 | 25,000 | $3.47 | $86.8K | 185,424 | SEC↗ |
| Hurlburt Elizabeth | EVP | S Sale | 2024-11-14 | 2024-11-18 | 140,027 | $11.18 | $1.57M | 45,397 | SEC↗ |
| Mistry Erin | EVP, Chief Commercial Office | P Buy | 2024-10-31 | 2024-12-13 | 1,500 | $9.99 | $15.0K | 52,011 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2024-05-10 | 2024-05-13 | 26,982 | $5.17 | $139.5K | 325,857 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | P Buy | 2024-03-13 | 2024-03-14 | 13,561 | $3.74 | $50.7K | 352,839 | SEC↗ |
| Duncan Gregory Scott | Director | A Award deriv | 2024-03-05 | 2024-03-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2024-03-05 | 2024-03-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2024-03-05 | 2024-03-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kaplan Myron | Director | A Award deriv | 2024-03-05 | 2024-03-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Stewart Robert A | Director | A Award deriv | 2024-03-05 | 2024-03-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lefkowitz Steven W | Director | A Award deriv | 2024-03-05 | 2024-03-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award deriv | 2024-01-12 | 2024-01-17 | 266,667 | — | $0 | 266,667 | SEC↗ |
| Mistry Erin | Chief Commercial Officer | A Award deriv | 2024-01-12 | 2024-01-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| David Matthew T | Chief Financial Officer | A Award deriv | 2024-01-12 | 2024-01-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A Award deriv | 2024-01-12 | 2024-01-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2024-01-12 | 2024-01-17 | 13,781 | $3.47 | $47.8K | 339,278 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award | 2024-01-12 | 2024-01-17 | 133,333 | — | $0 | 353,059 | SEC↗ |
| Mistry Erin | Chief Commercial Officer | A Award | 2024-01-12 | 2024-01-17 | 50,000 | — | $0 | 54,900 | SEC↗ |
| Mistry Erin | Chief Commercial Officer | F Tax w/h | 2024-01-12 | 2024-01-17 | 4,389 | $3.47 | $15.2K | 50,511 | SEC↗ |
| David Matthew T | Chief Financial Officer | A Award | 2024-01-12 | 2024-01-17 | 50,000 | — | $0 | 53,150 | SEC↗ |
| David Matthew T | Chief Financial Officer | F Tax w/h | 2024-01-12 | 2024-01-17 | 5,216 | $3.47 | $18.1K | 47,934 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A Award | 2024-01-12 | 2024-01-17 | 50,000 | — | $0 | 58,000 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | F Tax w/h | 2024-01-12 | 2024-01-17 | 4,603 | $3.47 | $16.0K | 53,397 | SEC↗ |
| DUNTON ALAN W | Director | P Buy | 2023-12-15 | 2023-12-18 | 3,000 | $3.30 | $9.9K | 15,250 | SEC↗ |
| DUNTON ALAN W | Director | P Buy | 2023-12-14 | 2023-12-18 | 3,000 | $3.45 | $10.3K | 12,250 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | A Award deriv | 2023-12-12 | 2023-12-14 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Zelnick Kaufman Beth | Chief Legal Officer | A Award | 2023-12-12 | 2023-12-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mistry Erin | Chief Commercial Officer | P Buy | 2023-11-17 | 2023-11-21 | 1,000 | $4.00 | $4.0K | 4,900 | SEC↗ |
| Lefkowitz Steven W | Director | M Exercise deriv | 2023-11-16 | 2023-11-17 | 15,000 | — | $0 | 0 | SEC↗ |
| Lefkowitz Steven W | Director | M Exercise | 2023-11-16 | 2023-11-17 | 15,000 | $2.25 | $33.8K | 75,498 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | P Buy | 2023-09-08 | 2023-09-08 | 10,000 | $3.71 | $37.1K | 219,726 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2023-05-18 | 2023-05-19 | 6,000 | $4.54 | $27.2K | 166,034 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award | 2023-05-17 | 2023-05-17 | 5,000 | $4.58 | $22.9K | 209,726 | SEC↗ |
| Stewart Robert A | Director | A Award | 2023-05-17 | 2023-05-17 | 10,000 | $4.37 | $43.7K | 11,000 | SEC↗ |
| DUNTON ALAN W | Director | A Award | 2023-05-17 | 2023-05-17 | 3,000 | $4.33 | $13.0K | 9,250 | SEC↗ |
| Costa Paulo F | Director | A Award | 2023-05-17 | 2023-05-17 | 10,000 | $4.65 | $46.5K | 10,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | P Buy | 2023-05-17 | 2023-05-18 | 5,000 | $4.58 | $22.9K | 209,726 | SEC↗ |
| Stewart Robert A | Director | P Buy | 2023-05-17 | 2023-05-18 | 10,000 | $4.37 | $43.7K | 11,000 | SEC↗ |
| DUNTON ALAN W | Director | P Buy | 2023-05-17 | 2023-05-18 | 3,000 | $4.33 | $13.0K | 9,250 | SEC↗ |
| Costa Paulo F | Director | P Buy | 2023-05-17 | 2023-05-18 | 10,000 | $4.65 | $46.5K | 10,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | F Tax w/h | 2023-05-10 | 2023-05-12 | 37,443 | $5.30 | $198.4K | 204,726 | SEC↗ |
| Stewart Robert A | Director | A Award deriv | 2023-04-13 | 2023-04-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Stewart Robert A | Director | A Award deriv | 2023-04-13 | 2023-04-17 | 14,200 | — | $0 | 14,200 | SEC↗ |
| Costa Paulo F | Director | A Award deriv | 2023-01-14 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| David Matthew T | Chief Financial Officer | A Award deriv | 2023-01-14 | 2023-01-18 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Duncan Gregory Scott | Director | A Award deriv | 2023-01-14 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2023-01-14 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A Award deriv | 2023-01-14 | 2023-01-18 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Kaplan Myron | Director | A Award deriv | 2023-01-14 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2023-01-14 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Lefkowitz Steven W | Director | A Award deriv | 2023-01-14 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Mounts Phoebe | General Counsel | A Award deriv | 2023-01-14 | 2023-01-18 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award deriv | 2023-01-14 | 2023-01-18 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Mistry Erin | Chief Commercial Officer | A Award deriv | 2023-01-14 | 2023-01-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | P Buy | 2022-11-15 | 2022-11-16 | 20,000 | $3.82 | $76.4K | 242,169 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | P Buy | 2022-08-24 | 2022-08-25 | 4,700 | $3.92 | $18.4K | 222,169 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2022-05-17 | 2022-05-18 | 5,000 | $3.78 | $18.9K | 160,034 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | P Buy | 2022-05-16 | 2022-05-17 | 10,000 | $3.38 | $33.8K | 217,469 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award deriv | 2022-05-10 | 2022-05-12 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Todisco Joseph | Chief Executive Officer | A Award | 2022-05-10 | 2022-05-12 | 207,469 | — | $0 | 207,469 | SEC↗ |
| Kaplan Myron | Director | A Award deriv | 2022-02-22 | 2022-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Lefkowitz Steven W | Director | A Award deriv | 2022-02-22 | 2022-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2022-02-22 | 2022-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Duncan Gregory Scott | Director | A Award deriv | 2022-02-22 | 2022-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Costa Paulo F | Director | A Award deriv | 2022-02-22 | 2022-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2022-02-22 | 2022-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| David Matthew T | Interim CEO and CFO | A Award deriv | 2022-02-18 | 2022-02-23 | 0 | — | $0 | 100,000 | SEC↗ |
| Mounts Phoebe | General Counsel | A Award deriv | 2022-02-18 | 2022-02-23 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A Award deriv | 2022-02-18 | 2022-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Nusbickel Thomas | EVP, Chief Commercial Office | A Award deriv | 2022-02-18 | 2022-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kaplan Myron | Director | G Gift | 2021-12-27 | 2021-12-29 | 5,000 | — | $0 | 150,034 | SEC↗ |
| Kaplan Myron | Director | G Gift | 2021-12-27 | 2021-12-29 | 5,000 | — | $0 | 145,034 | SEC↗ |
| Kaplan Myron | Director | G Gift | 2021-12-27 | 2021-12-29 | 5,000 | — | $0 | 140,034 | SEC↗ |
| Kaplan Myron | Director | G Gift | 2021-12-27 | 2021-12-29 | 20,000 | — | $0 | 155,034 | SEC↗ |
| David Matthew T | Interim CEO and CFO | P Buy | 2021-12-06 | 2021-12-07 | 1,000 | $4.50 | $4.5K | 3,150 | SEC↗ |
| David Matthew T | Interim CEO and CFO | P Buy | 2021-12-06 | 2021-12-07 | 1,000 | $4.50 | $4.5K | 3,150 | SEC↗ |
| David Matthew T | Interim CEO and CFO | P Buy | 2021-11-17 | 2021-11-19 | 1,000 | $5.07 | $5.1K | 2,150 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2021-11-16 | 2021-11-19 | 10,000 | $5.14 | $51.4K | 175,034 | SEC↗ |
| Mounts Phoebe | General Counsel | A Award deriv | 2021-11-01 | 2021-11-03 | 0 | — | $0 | 100,000 | SEC↗ |
| David Matthew T | Interim CEO and CFO | A Award deriv | 2021-11-01 | 2021-11-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | S Sale | 2021-05-21 | 2021-05-25 | 8,000 | $6.92 | $55.4K | 0 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2021-05-17 | 2021-05-19 | 15,000 | $6.03 | $90.5K | 165,034 | SEC↗ |
| Nusbickel Thomas | EVP, Chief Commercial Office | A Award deriv | 2021-05-13 | 2021-05-20 | 260,000 | — | $0 | 260,000 | SEC↗ |
| Nusbickel Thomas | EVP, Chief Commercial Office | A Award deriv | 2021-05-13 | 2021-05-20 | 7,500 | — | $0 | 7,500 | SEC↗ |
| Chief Financial Officer | A Award deriv | 2021-01-11 | 2021-01-13 | 80,000 | — | $0 | 80,000 | SEC↗ | |
| Mounts Phoebe | General Counsel | A Award deriv | 2021-01-11 | 2021-01-13 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Baluch Khoso | Chief Executive Officer | A Award deriv | 2021-01-11 | 2021-01-13 | 320,000 | — | $0 | 320,000 | SEC↗ |
| Costa Paulo F | Director | A Award deriv | 2021-01-11 | 2021-01-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2021-01-11 | 2021-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Duncan Gregory Scott | Director | A Award deriv | 2021-01-11 | 2021-01-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Kaplan Myron | Director | A Award deriv | 2021-01-11 | 2021-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lefkowitz Steven W | Director | A Award deriv | 2021-01-11 | 2021-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2021-01-11 | 2021-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EVP, Head of Clinical Ops. | A Award deriv | 2021-01-11 | 2021-01-13 | 140,000 | — | $0 | 140,000 | SEC↗ | |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | A Award deriv | 2021-01-11 | 2021-01-13 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2020-11-16 | 2020-11-18 | 3,583 | — | $0 | 3,583 | SEC↗ |
| Duncan Gregory Scott | Director | A Award deriv | 2020-11-02 | 2020-11-04 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Duncan Gregory Scott | Director | A Award deriv | 2020-11-02 | 2020-11-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Costa Paulo F | Director | A Award deriv | 2020-09-15 | 2020-09-17 | 3,750 | — | $0 | 3,750 | SEC↗ |
| Costa Paulo F | Director | A Award deriv | 2020-09-15 | 2020-09-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Lefkowitz Steven W | Director | P Buy | 2020-09-04 | 2020-09-09 | 3,500 | $4.00 | $14.0K | 58,283 | SEC↗ |
| Lefkowitz Steven W | Director | P Buy | 2020-09-04 | 2020-09-09 | 2,215 | $3.98 | $8.8K | 60,498 | SEC↗ |
| David Matthew T | Chief Financial Officer | P Buy | 2020-09-03 | 2020-09-08 | 1,150 | $4.07 | $4.7K | 1,150 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2020-09-02 | 2020-09-04 | 15,300 | $4.27 | $65.3K | 150,034 | SEC↗ |
| Khan Mehmood | Director | P Buy | 2020-08-19 | 2020-08-20 | 8,433 | $4.90 | $41.3K | 178,767 | SEC↗ |
| Khan Mehmood | Director | P Buy | 2020-08-19 | 2020-08-20 | 9,404 | $4.91 | $46.2K | 170,334 | SEC↗ |
| Khan Mehmood | Director | P Buy | 2020-08-18 | 2020-08-20 | 21,082 | $4.86 | $102.5K | 160,930 | SEC↗ |
| Khan Mehmood | Director | P Buy | 2020-08-18 | 2020-08-20 | 2,331 | $4.60 | $10.7K | 135,348 | SEC↗ |
| Khan Mehmood | Director | P Buy | 2020-08-18 | 2020-08-20 | 4,500 | $4.62 | $20.8K | 139,848 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2020-08-14 | 2020-08-17 | 4,770 | — | $0 | 4,770 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | P Buy | 2020-08-14 | 2020-08-17 | 10,000 | $4.35 | $43.5K | 96,878 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | P Buy | 2020-08-14 | 2020-08-17 | 7,500 | $4.14 | $31.0K | 86,878 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | P Buy | 2020-08-14 | 2020-08-17 | 10,000 | $4.16 | $41.6K | 79,378 | SEC↗ |
| Baluch Khoso | Chief Executive Officer | P Buy | 2020-08-13 | 2020-08-17 | 4,830 | $4.14 | $20.0K | 60,905 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2020-08-13 | 2020-08-17 | 15,000 | $4.08 | $61.2K | 134,734 | SEC↗ |
| Mounts Phoebe | General Counsel | P Buy | 2020-08-13 | 2020-08-17 | 2,525 | $4.03 | $10.2K | 7,200 | SEC↗ |
| DUNTON ALAN W | Director | P Buy | 2020-08-12 | 2020-08-14 | 5,000 | $3.95 | $19.8K | 6,250 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2020-05-15 | 2020-05-18 | 5,253 | — | $0 | 5,253 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2020-05-15 | 2020-05-18 | 10,000 | $3.85 | $38.5K | 119,734 | SEC↗ |
| David Matthew T | EVP, Chief Financial Officer | A Award deriv | 2020-05-11 | 2020-05-13 | 125,000 | $4.08 | $510.0K | 125,000 | SEC↗ |
| David Matthew T | EVP, Chief Financial Officer | A Award deriv | 2020-05-11 | 2020-05-13 | 125,000 | $5.63 | $703.8K | 125,000 | SEC↗ |
| Mounts Phoebe | General Counsel | A Award deriv | 2020-05-11 | 2020-05-13 | 50,000 | $4.08 | $204.0K | 50,000 | SEC↗ |
| Mounts Phoebe | General Counsel | A Award deriv | 2020-05-11 | 2020-05-13 | 50,000 | $5.63 | $281.5K | 50,000 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A Award deriv | 2020-05-11 | 2020-05-13 | 37,500 | $5.63 | $211.1K | 37,500 | SEC↗ |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A Award deriv | 2020-05-11 | 2020-05-13 | 37,500 | $4.08 | $153.0K | 37,500 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | A Award deriv | 2020-05-11 | 2020-05-13 | 37,500 | $5.63 | $211.1K | 37,500 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | A Award deriv | 2020-05-11 | 2020-05-13 | 37,500 | $4.08 | $153.0K | 37,500 | SEC↗ |
| Baluch Khoso | Chief Executive Officer | P Buy | 2020-03-18 | 2020-03-18 | 3,500 | $2.61 | $9.1K | 56,075 | SEC↗ |
| Mounts Phoebe | General Counsel | P Buy | 2020-03-18 | 2020-03-19 | 3,250 | $3.05 | $9.9K | 4,675 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2020-02-25 | 2020-02-27 | 15,000 | $5.63 | $84.5K | 15,000 | SEC↗ |
| Masson Elizabeth | EVP, Head of Clinical Ops. | A Award deriv | 2020-02-25 | 2020-02-27 | 24,764 | $5.63 | $139.4K | 24,764 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | A Award deriv | 2020-02-25 | 2020-02-27 | 24,764 | $5.63 | $139.4K | 24,764 | SEC↗ |
| Baluch Khoso | Chief Executive Officer | A Award deriv | 2020-02-25 | 2020-02-27 | 100,630 | $5.63 | $566.5K | 100,630 | SEC↗ |
| Kaplan Myron | Director | A Award deriv | 2020-02-25 | 2020-02-27 | 15,000 | $5.63 | $84.5K | 15,000 | SEC↗ |
| Mounts Phoebe | General Counsel | A Award deriv | 2020-02-25 | 2020-02-27 | 24,764 | $5.63 | $139.4K | 24,764 | SEC↗ |
| Khan Mehmood | Director | A Award deriv | 2020-02-25 | 2020-02-27 | 15,000 | $5.63 | $84.5K | 15,000 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2020-02-25 | 2020-02-27 | 15,000 | $5.63 | $84.5K | 15,000 | SEC↗ |
| Lefkowitz Steven W | Director | A Award deriv | 2020-02-25 | 2020-02-27 | 15,000 | $5.63 | $84.5K | 15,000 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,706 | — | $0 | 1,706 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2020-02-14 | 2020-02-20 | 1,706 | — | $0 | 1,706 | SEC↗ |
| Lefkowitz Steven W | Director | X Exercise deriv | 2020-01-07 | 2020-02-27 | 3,000 | $4.50 | $13.5K | 3,000 | SEC↗ |
| Lefkowitz Steven W | Director | X Exercise deriv | 2020-01-07 | 2020-02-27 | 4,500 | $4.50 | $20.3K | 4,500 | SEC↗ |
| Lefkowitz Steven W | Director | X Exercise | 2020-01-07 | 2020-02-27 | 4,500 | $4.50 | $20.3K | 59,776 | SEC↗ |
| Lefkowitz Steven W | Director | X Exercise | 2020-01-07 | 2020-02-27 | 3,000 | $4.50 | $13.5K | 30,152 | SEC↗ |
| Mounts Phoebe | General Counsel | P Buy | 2019-12-30 | 2020-01-02 | 1,425 | $7.04 | $10.0K | 1,425 | SEC↗ |
| Khan Mehmood | Director | P Buy | 2019-12-13 | 2019-12-17 | 17,000 | $6.58 | $111.9K | 133,017 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2019-11-14 | 2019-11-18 | 2,099 | — | $0 | 2,099 | SEC↗ |
| Cook Robert W. | Chief Financial Officer | P Buy | 2019-09-30 | 2019-10-01 | 1,000 | $6.88 | $6.9K | 27,517 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2019-09-30 | 2019-10-01 | 5,000 | $6.81 | $34.0K | 109,734 | SEC↗ |
| Lefkowitz Steven W | Director | P Buy | 2019-09-27 | 2019-10-01 | 5,000 | $6.75 | $33.8K | 55,276 | SEC↗ |
| Baluch Khoso | Chief Executive Officer | A Award deriv | 2019-09-26 | 2019-09-30 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Dillione Janet | Director | P Buy | 2019-08-16 | 2019-08-16 | 6,147 | $8.19 | $50.3K | 53,473 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2019-08-16 | 2019-08-16 | 6,000 | $8.06 | $48.4K | 104,734 | SEC↗ |
| Cook Robert W. | Chief Financial Officer | P Buy | 2019-08-16 | 2019-08-19 | 1,000 | $8.18 | $8.2K | 26,517 | SEC↗ |
| Cook Robert W. | Chief Financial Officer | P Buy | 2019-08-16 | 2019-08-19 | 1,000 | $8.18 | $8.2K | 26,517 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2019-08-14 | 2019-08-16 | 945 | — | $0 | 945 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2019-07-12 | 2019-07-16 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DUNTON ALAN W | Director | A Award | 2019-07-12 | 2019-07-16 | 1,250 | — | $0 | 1,250 | SEC↗ |
| Dillione Janet | Director | A Award deriv | 2019-05-15 | 2019-05-17 | 1,126 | — | $0 | 226 | SEC↗ |
| Dillione Janet | Director | P Buy | 2019-05-15 | 2019-05-17 | 11,144 | $6.74 | $75.1K | 47,326 | SEC↗ |
| Mounts Phoebe | General Counsel | A Award deriv | 2019-05-01 | 2019-05-24 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Cook Robert W. | Chief Financial Officer | P Buy | 2019-03-29 | 2019-04-01 | 100 | $9.35 | $935 | 25,517 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | P Buy | 2019-03-26 | 2019-03-27 | 5,000 | $7.73 | $38.6K | 69,378 | SEC↗ |
| Baluch Khoso | Chief Executive Officer | P Buy | 2019-03-26 | 2019-03-27 | 2,500 | $7.55 | $18.9K | 52,575 | SEC↗ |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | P Buy | 2019-03-25 | 2019-03-25 | 15,000 | $1.69 | $25.4K | 321,890 | SEC↗ |
| Kaplan Myron | Director | P Buy | 2019-03-22 | 2019-03-22 | 20,000 | $1.65 | $33.0K | 493,666 | SEC↗ |
| Dillione Janet | Director | P Buy | 2019-03-18 | 2019-03-20 | 42,000 | $1.67 | $70.1K | 180,909 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2019-03-01 | 2019-05-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DUNTON ALAN W | Director | A Award deriv | 2019-03-01 | 2019-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |